Table 1.

Behavioural parameters in the habituated open field and forelimb grip strength test components of the neuromotor tolerability test battery (Experiment 1). Administration of CBG at doses up to 120 mg/kg had no deleterious effects on locomotor activity or grip strength performance nor any effect on anxiety-like behaviours. Data presented as mean ± SEM and analysed by one-way repeated measures ANOVA, all groups n = 12

	CBG (mg/kg)
	0	30	60	120
Open field test
Line crosses	136 (±18)	145 (±14)	142 (±6)	130 (±10)
Central sector duration (s)	23.1 (±4.7)	26.0 (±3.9)	33.1 (±5.9)	19.2 (±2.7)
Latency to central sector entry (s)	74.7 (±21.4)	70.2 (±24.3)	64.9 (±17.7)	85.9 (±20.7)
Grip strength test
Grip strength (kgf)	0.811 (±0.062)	0.747 (±0.044)	0.762 (±0.032)	0.740 (±0.051)